Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.40 |
| ▸ | STAT1 | P42224 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29219910 | 0.92 | ALDH1A1 (0.47) | ALDH1A1TSHRKDM4ENPC1MAPT | |
| SCHEMBL14060267 | 0.91 | ALDH1A1 (0.46) | ALDH1A1TSHRKDM4ENPC1MAPT | |
| SCHEMBL16205894 | 0.85 | ALDH1A1 (0.47) | ALDH1A1TSHRKDM4ENPC1MAPT | |
| SCHEMBL16076545 | 0.84 | ALDH1A1 (0.49) | ALDH1A1TSHRKDM4ENPC1MAPT | |
| SCHEMBL27999386 | 0.83 | ALDH1A1 (0.51) | ALDH1A1TSHRKDM4ENPC1MAPT | |
| SCHEMBL697079 | 0.83 | ALDH1A1 (0.51) | ALDH1A1TSHRKDM4ENPC1MAPT | |
| SCHEMBL2541634 | 0.83 | ALDH1A1 (0.60) | ALDH1A1TSHRKDM4ENPC1MAPT | |
| SCHEMBL18740423 | 0.83 | ALDH1A1 (0.47) | ALDH1A1TSHRKDM4ENPC1MAPT | |
| SCHEMBL11987589 | 0.83 | ALDH1A1 (0.55) | ALDH1A1TSHRKDM4ENPC1MAPT | |
| SCHEMBL4898922 | 0.83 | ALDH1A1 (0.55) | ALDH1A1TSHRKDM4ENPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1023 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250206712-A1 | 5-HALOMETHYLFURFURAL PRODUCTION METHOD INVOLVING PRETREATMENT STEP | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2025-06-26 | — | — | US | claimed |
| EP-4570790-A1 | 5-HALOMETHYLFURFURAL PRODUCTION METHOD INVOLVING PRETREATMENT STEP | Korea Research Institute of Chemical Technology (KR) | 2025-06-18 | — | — | EP | claimed |
| US-20250188047-A1 | METHOD FOR PREPARING 5-ACETOXYMETHYL FURFURAL (AMF) FROM SUGAR INGREDIENTS AND METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID (FDCA) COMPRISING SAME | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2025-06-12 | — | — | US | claimed |
| US-20250171411-A1 | SYNTHESIS OF 5-ACETOXYMETHYL FURFURAL IN THE PRESENCE OF RECYCLABLE SALT CATALYSTS | CELLUFLUX LTD. (IL) | 2025-05-29 | — | — | US | claimed |
| US-20250136566-A1 | FURAN DICARBOXYLIC ACID COMPOUND, METHOD FOR PREPARING FURAN DICARBOXYLIC ACID COMPOUND, POLYESTER, AND MEHTOD FOR PREPARING POLYESTER | KOLON INDUSTRIES, INC. (KR) | 2025-05-01 | — | — | US | claimed |
| EP-4486731-A1 | SYNTHESIS OF 5-ACETOXYMETHYL FURFURAL IN THE PRESENCE OF RECYCLABLE SALT CATALYSTS | Celluflux Ltd. (IL) | 2025-01-08 | — | — | EP | claimed |
| EP-4438599-A1 | FURANDICARBOXYLIC ACID COMPOUND, METHOD FOR PRODUCING FURANDICARBOXYLIC ACID COMPOUND, POLYESTER, AND METHOD FOR PRODUCING POLYESTER | Kolon Industries, Inc. (KR) | 2024-10-02 | — | — | EP | claimed |
| CN-118234714-A | Furandicarboxylic acid compound, method for producing furandicarboxylic acid compound, polyester, and method for producing polyester | 可隆工业株式会社 | 2024-06-21 | — | — | CN | claimed |
| WO-2024071951-A1 | 5-HALOMETHYLFURFURAL PRODUCTION METHOD INVOLVING PRETREATMENT STEP | 한국화학연구원 | 2024-04-04 | — | — | WO | claimed |
| WO-2023172033-A1 | METHOD FOR PREPARING 5-ACETOXYMETHYL FURFURAL (AMF) FROM SUGAR INGREDIENTS AND METHOD FOR PREPARING 2,5-FURANDICARBOXYLIC ACID (FDCA) COMPRISING SAME | 한국화학연구원 | 2023-09-14 | — | — | WO | claimed |
| CN-101421259-A | Synthesis method and application of 5-hydroxymethylfurfural organic acid ester | FURANIX TECHNOLOGIES BV (NL) | 2009-04-29 | — | — | CN | claimed |
| EP-2001859-A1 | METHOD FOR THE SYNTHESIS OF ORGANIC ACID ESTERS OF 5-HYDROXYMETHYLFURFURAL AND THEIR USE | Furanix Technologies B.V (NL) | 2008-12-17 | — | — | EP | claimed |
| WO-2007104515-A1 | METHOD FOR THE SYNTHESIS OF ORGANIC ACID ESTERS OF 5-HYDROXYMETHYLFURFURAL AND THEIR USE | FURANIX TECHNOLOGIES B.V. (NL) | 2007-09-20 | — | — | WO | claimed |
| US-20040132807-A1 | Aurones as telomerase inhibitors | PHARMACIA ITALIA SPA (IT) | 2004-07-08 | — | — | US | claimed |
| EP-1381359-A1 | AURONES AS TELOMERASE INHIBITORS | Pharmacia Italia S.p.A. (IT) | 2004-01-21 | — | — | EP | claimed |
| WO-2002083123-A1 | AURONES AS TELOMERASE INHIBITORS | PHARMACIA ITALIA SPA (IT) | 2002-10-24 | — | — | WO | claimed |
| EP-0674233-B1 | Recording sheets | XEROX CORP (US) | 2000-05-24 | — | — | EP | claimed |
| US-5928765-A | Recording sheets | XEROX CORPORATION (US) | 1999-07-27 | — | — | US | claimed |
| EP-0674233-A2 | Recording sheets | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| US-4255319-A | PHOSPHINE INHIBITION; NONTOXIC; STORAGE STABILITY; MATERIALS HANDLING | UNION CARBIDE CORPORATION (US) | 1981-03-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040132807-A1 | Aurones as telomerase inhibitors | TERT, TERF2, TERF2IP | ALDH1A1 1344/4885TSHR 3411/4885KDM4E 818/4885 |
| US-20250171411-A1 | SYNTHESIS OF 5-ACETOXYMETHYL FURFURAL IN THE PRESENCE OF RECYCLABLE SALT CATALYSTS | GRHPR, APEH, ME1 | ALDH1A1 294/4885TSHR 3102/4885KDM4E 460/4885 |
| US-20250136566-A1 | FURAN DICARBOXYLIC ACID COMPOUND, METHOD FOR PREPARING FURAN DICARBOXYLIC ACID COMPOUND, POLYESTER, AND MEHTOD FOR PREPARING POLYESTER | HADH, DHODH, HAAO | ALDH1A1 956/4885TSHR 4028/4885KDM4E 725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.